Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
Historik

Vælg chat via ovenstående menu
Luk reklame

DANMARKS STØRSTE INVESTORSITE MED DEBAT, CHAT OG NYHEDER
Q&A med Genmab A/S, 27 November Kl. 16:00 Læs mere her

Sanofi køber 78% af indisk vaccinefirma


15811 akademikeren 27/7 2009 14:35
Oversigt

LONDON (MarketWatch) -- Sanofi-Aventis on Monday reached a pact to buy a 78% stake of Shantha Biotechnics for 550 million euros ($783 million), a deal that helps the firm develop in two fast-growing areas, vaccines and emerging markets.

Sanofi (SNY 33.10, +0.30, +0.91%) said it's buying the stake from Merieux Alliance, a family holding with stakes in a variety of health-care firms.

Shantha is based in Hyderabad, India, and is expected to have sales of $90 million this year.

Dr. Varaprasad Reddy, the company's founder, will continue to run the firm as managing director. Sanofi will form a joint committee founded by Alain Merieux on vaccine strategy for emerging markets.

Vaccines are a fast growing area that have come into the spotlight as bird flu and swine flu have spread worldwide.

Roche and GlaxoSmithKline both credited vaccines in helping drive second-quarter performance. See Roche story. See Glaxo story.

Sanofi's second-quarter results are due Wednesday. In the first quarter, vaccines accounted for 7% of the company's revenue.

Shantha works with Unicef and PAHO to supply vaccines to international markets in the Asia-Pacific, Africa and Latin America regions.

Sanofi shares rose 0.4% in Paris.



27/7 2009 15:14 collersteen 015812



Mon det er grunden til interessen for Bava her på det sidste..?
Selvom omsætningen ikke er prangende, er det dog stadig pænt overn normalen når omsætningen kan måles med 5cifre.... og 10-15% op de sidste par dage er vel ganske fornuftigt.



27/7 2009 15:18 akademikeren 015813



Jeg tror specielt GSKs vaccineforretning har fået andre pharmavirksomheder til at slikke sig om munden. Men om det lige giver noget for bavarian ved jeg ikke. Det kan også være den mere generelle appetit på biotek efter sidste uges opkøb af medarex.



TRÅDOVERSIGT